close

A A A
Menu

National Adult Vaccination Program - Podcasts and Webinars

Article Index

Podcasts

Understanding the Vaccine Development Process

The process of bringing a vaccine to market takes extensive research and safety monitoring. Dr. Gordon Douglas explains the steps from preclinical studies to vaccine licensure, and discusses his own experience developing vaccines at a major manufacturer for 30 years. He also shares lessons learned from clinical trials during the COVID-19 pandemic, including the importance of participant diversity. 

GuestR. Gordon Douglas, Jr, MD, Professor Emeritus, Weill Cornell Medical College

Host: Jo-Ana Chase, PhD, APRN-BC, Associate Professor, Sinclair School of Nursing, University of Missouri Health

This podcast episode is supported by Seqirus. Content was developed by The Gerontological Society of America (GSA).

Applying Risk Communication Models to Immunization Discussions

Communicating the risks and benefits of immunization can be challenging, as the language of science may not always be well understood by the public. Dr. Aaron Scherer shares his research on risk communication and infectious disease, what we can learn from outbreak communication with older adults, and his thoughts on future opportunities in the field.

GuestAaron Scherer, MA, PhD, Assistant Professor of Internal Medicine - General Internal Medicine, University of Iowa

Host: Cheryl Ann Monturo, PhD, MBE, ACNP-BC, Senior Nurse Research Scientist Chester County Hospital/Penn Medicine; Professor of Nursing West Chester University

This podcast episode is supported by Seqirus. Content was developed by The Gerontological Society of America (GSA).

Integrating Immunization in Long-Term Care

A routine immunization program in long-term care facilities can protect residents who are most at risk of poor outcomes if they contract a vaccine-preventable disease, however systemic challenges contribute to stagnant vaccination rates among residents and low vaccination rates among staff. In this episode, Dr. Barbara Resnick discusses her work in improving immunization rates in long-term care, using behavior motivation techniques to encourage staff and residents to get vaccinated, and what she sees as opportunities for future researchers and practitioners.

Guest: Barbara Resnick, PhD, RN, CRNP, FAAN, FAANP, Sonya Ziporkin Gershowitz Chair in Gerontology, University of Maryland School of Nursing

Host: Justine Sefcik, PhD, RN, Assistant Professor, Drexel University College of Nursing and Health Professions; Co-convener, GSA Interest Group on Nursing

This podcast episode is supported by Seqirus. Content was developed by The Gerontological Society of America (GSA).

Webinars

Risk Communication for Vaccine Preventable Illnesses: Addressing Concerns, Facilitating Behavior Change

November 2021

Communicating effectively with older adults about risk requires an understanding of biases, perceptions and how we learn from science. This Momentum Discussion will delve into what is known about infectious disease and prevention communication, how to facilitate uptake of preventive health services, and how can we improve education in prevention. The panel will utilize case studies to showcase how to improve the practice of recommending and following through on preventive services.

Panelists:

  • Robin L. P. Jump, MD, PhD. Geriatric Research, Education and Clinical Center (GRECC), VA Northeast Ohio Healthcare System, Associate Professor of Medicine, Case Western Reserve University School of Medicine (Moderator)
  • Barbara Resnick, PhD, CRNP, Professor, University of Maryland, Sonya Ziporkin Gershowitz Chair in Gerontology
  • Aaron Scherer, PhD, Assistant Professor of Internal Medicine, University of Iowa, Director of the Healthcare and Public Perceptions of Immunizations (HaPPI) Survey Collaborative

Supported by Johnson & Johnson Health Sciences, Inc.

Getting to Know the NVAC: Connecting the Immunization and Aging Communities

October 26, 2021

This webinar, Getting to Know the NVAC, will review the purpose and structure of the National Vaccine Advisory Committee – such as who is on the Committee, what and how they make their decisions, and why the Committee matters. It will also share ways to engage with NVAC on issues related to older adult vaccination.

This webinar was developed by The Gerontological Society of America with support from Pfizer.

Getting to Know the ACIP: Connecting the Immunization and Aging Communities

October 25, 2021

This webinar, Getting to Know the ACIP, will review the purpose and structure of the Advisory Committee on Immunization Practices – such as who is on the Committee, what and how they make their decisions, and why the Committee matters. It will also share ways to engage with ACIP on issues related to older adult vaccination.

This webinar was developed by The Gerontological Society of America with support from Pfizer.

Understanding the Value of Enhanced Influenza Vaccine Products in Long-Term Care Settings

September 17, 2020

There are many benefits to preventing flu transmission in long-term care settings yet only about two-thirds of nursing home residents receive annual influenza vaccinations—one of the best known preventive strategies. The COVID-19 pandemic has further amplified the need for effective infection control in these settings. Compared with standard-dose influenza vaccines, enhanced influenza vaccines are not only more effective in preventing disease in older adults, they also provide a higher return on investment. This webinar is designed to help nursing home administrators, infection control teams, and other long-term care staff to (1) understand the benefits of using enhanced influenza vaccine products in residents and (2) learn practical tips that can help leadership and staff consistently apply immunization practices.

Presented by:

  • R. Gordon Douglas, MD, Chair, National Adult Vaccination Program Workgroup; Professor Emeritus, Weill Cornell Medical College (Moderator)
  • David H. Canaday, MD, Professor of Medicine, Case Western Reserve University; Associate Director, Geriatric, Research, Education, and Clinical Center (GRECC), Louis Stokes Cleveland VA Medical Center; Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center
  • Sherry A. Greenberg, PhD, RN, GNP-BC, FGSA, FAANP, FAAN, Associate Professor, Seton Hall University College of Nursing; President-Elect, Gerontological Advanced Practice Nurses Association
  • Barbara Resnick, PhD, RN, CRNP, FAAN, FAANP, Professor, University of Maryland School of Nursing; Co-Director, Biology and Behavior Across the Lifespan Organized Research Center; Sonya Ziporkin Gershowitz Chair in Gerontology

This program was jointly developed by GSA, the Gerontological Advanced Practice Nurses Association, and AMDA – The Society for Post-Acute and Long-Term Care Medicine, with support from Sanofi.

Understanding Respiratory Syncytial Virus (RSV), Influenza, and COVID-19: Preparing for the Fall

August 30, 2020

Respiratory syncytial virus, or RSV, causes 177,000 hospitalizations and 14,000 deaths in older adults each year. Those over 65, adults with chronic heart or lung disease, and adults with weakened immune systems are particularly at risk. Yet RSV remains underdiagnosed.

In this one-hour webinar, experts will answer questions about RSV and how to prepare for the fall, when influenza and COVID-19 will be co-circulating. Participants will understand RSV and its impact on older adults; the challenges of distinguishing between RSV, influenza, and COVID-19; and how to keep older adults healthy with so many respiratory viruses circulating, particularly in a long-term care facility. Speakers will address gaps in understanding and research opportunities, as well as what gives them optimism for the fall respiratory illness season.

Presented by:

  • Robin Jump, MD, PhD – Case Western Reserve University, Louis Stokes Cleveland VA Medical Center
  • Lindsay Kim, MD, MPH – Centers for Disease Control and Prevention
  • Helen “Keipp” Talbot, MD, MPH – Vanderbilt University Medical Center

This Momentum Discussion is supported by Johnson and Johnson Health Systems, Inc. Content is developed by GSA.

Share This Page!

Print Page